尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Cleary Chris. Officer active across 1 company, notably Orchestra BioMed Holdings, Inc.. Aggregated, 6 reports have been published. History available since 3 February 2025. The latest transaction was disclosed on 12 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Cleary Chris appears in 4 filings in total. The 4 sampled filings, all at Orchestra BioMed Holdings, Inc. on XNAS, run from 2025-02-05 to 2026-06-25 and are mainly attributed transactions, with buy and sell amounts of EUR 0 in this sample. He is also listed as Director at Orchestra BioMed Holdings, Inc.